Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
HZNP Horizon Pharma Public Limited Company daily Stock Chart
HZNP [NASD]
Horizon Pharma Public Limited Company
Healthcare | Drugs - Generic | Ireland
financial highlights | statements
Index- P/E- EPS (ttm)-1.74 Insider Own0.60% Shs Outstand165.14M Perf Week12.92%
Market Cap3.61B Forward P/E11.81 EPS next Y1.85 Insider Trans-11.33% Shs Float164.14M Perf Month18.62%
Income-285.60M PEG- EPS next Q0.55 Inst Own91.80% Short Float6.16% Perf Quarter10.47%
Sales1.13B P/S3.20 EPS this Y-186.70% Inst Trans-0.36% Short Ratio6.85 Perf Half Y45.96%
Book/sh5.49 P/B3.98 EPS next Y9.99% ROA-5.20% Target Price25.55 Perf Year62.82%
Cash/sh4.89 P/C4.47 EPS next 5Y16.40% ROE-23.20% 52W Range12.55 - 23.38 Perf YTD49.66%
Dividend- P/FCF15.84 EPS past 5Y-5.70% ROI-12.60% 52W High-6.54% Beta1.09
Dividend %- Quick Ratio1.90 Sales past 5Y123.70% Gross Margin58.60% 52W Low74.09% ATR1.08
Employees990 Current Ratio1.90 Sales Q/Q19.80% Oper. Margin-13.10% RSI (14)66.14 Volatility6.95% 5.70%
OptionableYes Debt/Eq2.06 EPS Q/Q138.60% Profit Margin-18.70% Rel Volume1.19 Prev Close21.74
ShortableYes LT Debt/Eq2.06 EarningsNov 07 BMO Payout- Avg Volume1.48M Price21.85
Recom2.10 SMA2012.92% SMA5012.74% SMA20029.48% Volume1,750,713 Change0.51%
Jun-27-18Downgrade Citigroup Buy → Neutral
Jan-12-18Upgrade Mizuho Neutral → Buy $12 → $18
Sep-28-17Initiated Goldman Buy $16
Jun-16-17Initiated Cantor Fitzgerald Overweight $13
May-09-17Reiterated Stifel Buy $35 → $20
May-09-17Downgrade Mizuho Buy → Neutral $22 → $10
Feb-28-17Reiterated Mizuho Buy $25 → $22
Dec-16-16Upgrade Mizuho Neutral → Buy $14 → $25
Dec-09-16Downgrade Mizuho Buy → Neutral $30 → $14
Nov-28-16Upgrade Citigroup Neutral → Buy
Nov-08-16Reiterated Mizuho Buy $29 → $30
Oct-31-16Reiterated Mizuho Buy $33 → $29
Sep-13-16Reiterated Mizuho Buy $30 → $33
Jul-11-16Upgrade Morgan Stanley Underweight → Equal-Weight $24
Jun-06-16Initiated Goldman Buy $24
May-10-16Reiterated Mizuho Buy $25 → $24
May-03-16Reiterated Mizuho Buy $34 → $25
Jan-19-16Resumed Jefferies Buy $31
Jan-06-16Resumed Citigroup Neutral
Dec-17-15Initiated Goldman Buy
Nov-13-18 12:51PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
Nov-12-18 04:15PM  IBD Stock Of The Day Nears Buy Point As It Outperforms Big Pharma Rivals Investor's Business Daily
Nov-08-18 11:13AM  Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise Zacks
07:00AM  Why Horizon Pharma PLC Stock Is Spiking Today Motley Fool
Nov-07-18 04:11PM  This Pharma Stock Broke Out In Bullish Fashion Here's Why Investor's Business Daily +15.97%
11:10AM  Edited Transcript of HZNP earnings conference call or presentation 7-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
09:20AM  Horizon Pharma (HZNP) Tops Q3 Earnings and Revenue Estimates Zacks
08:15AM  Horizon Pharma: 3Q Earnings Snapshot Associated Press
07:00AM  Horizon Pharma plc Reports Third-Quarter Net Sales Growth of 20 Percent Driven by Orphan and Rheumatology Net Sales Growth of 25 Percent; Increases Full-Year 2018 Adjusted EBITDA Guidance Business Wire
Nov-02-18 09:30AM  The Chicago Tribune Names Horizon Pharma plc a 2018 Top Workplace Business Wire
Oct-31-18 10:32AM  Horizon Pharma (HZNP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-29-18 05:57PM  Horizon Pharma plc Announces Presentation of Results of 48 Week Off-Therapy Follow-Up to the Phase 2 Trial of Teprotumumab at 2018 American Academy of Ophthalmology (AAO) Annual Meeting Business Wire
08:00AM  Today's Research Reports on Trending Tickers: TherapeuticsMD and Horizon Pharma Public ACCESSWIRE
Oct-25-18 01:00PM  Horizon Pharma plc Presents Multiple Retrospective Analyses Showing Kidney Transplant Recipients Have Higher Rates of Gout and Increased Disease Severity Business Wire
08:00AM  Horizon Pharma plc to Participate in Investor Conferences in November Business Wire
Oct-22-18 08:00AM  Horizon Pharma plc Announces Multiple Data Presentations Highlighting the Growing Burden of Uncontrolled Gout at the 2018 ACR/ARHP Annual Meeting Business Wire
Oct-19-18 08:50AM  Market Trends Toward New Normal in Endeavour Silver, Triton International, Resonant, Radware, Horizon Pharma Public, and Ensco plc Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-18-18 09:16AM  FORTUNE and Great Place to Work® Name Horizon Pharma plc to 2018 Best Small & Medium Workplaces for Third Consecutive Year Business Wire
Oct-10-18 08:00AM  Today's Research Reports on Trending Tickers: Agile Therapeutics and Horizon Pharma ACCESSWIRE
08:00AM  Horizon Pharma plc to Release Third-Quarter 2018 Financial Results and Host Webcast on Nov. 7, 2018 Business Wire
Oct-04-18 09:02AM  Horizon Pharma plc Announces Presentation of Data From 48 Week Off-Therapy Follow-Up to the Phase 2 Trial of Teprotumumab Business Wire
Sep-27-18 11:00AM  The North American Pediatric Renal Trials and Collaborative Studies and Horizon Pharma plc Announce New Long-Term Cystinosis Registry Business Wire
08:00AM  Horizon Pharma plc Initiates Clinical Trial to Evaluate KRYSTEXXA® (pegloticase injection) with Methotrexate to Enhance Response Rates for People Living with Uncontrolled Gout Business Wire
Sep-25-18 08:00AM  Horizon Pharma plc to Present 48-Week Follow-Up Analysis of the Teprotumumab Phase 2 Trial at the Annual Meeting of the American Thyroid Association Business Wire
Sep-07-18 09:30AM  Horizon Pharma (HZNP) Down 1.9% Since Last Earnings Report: Can It Rebound? Zacks
Sep-05-18 05:34PM  Horizon Pharma Completes Enrollment in Eye Disease Study Zacks
Sep-04-18 08:00AM  Horizon Pharma plc to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference Business Wire
07:00AM  Horizon Pharma plc Completes Enrollment of Confirmatory Phase 3 Trial of Teprotumumab Ahead of Schedule Business Wire
Aug-27-18 05:44AM  Edited Transcript of HZNP earnings conference call or presentation 8-Aug-18 12:00pm GMT Thomson Reuters StreetEvents
Aug-24-18 08:35AM  These 3 Value Stocks Are Absurdly Cheap Right Now Motley Fool
Aug-22-18 06:22AM  Horizon Pharma (HZNP) Boasts Robust Pipeline Amid Competition Zacks
Aug-21-18 08:10AM  Investor Expectations to Drive Momentum within Materialise NV, Southern First Bancshares, Ensco plc, Corbus Pharmaceuticals, TCP Capital, and Horizon Pharma Public Discovering Underlying Factors of Influence GlobeNewswire
Aug-09-18 09:17AM  Horizon Pharma (HZNP) Q2 Earnings & Sales Beat, Shares Rise Zacks
Aug-08-18 03:51PM  Here's Why Horizon Pharma PLC Rose by Double Digits Today Motley Fool +10.79%
08:50AM  Horizon Pharma (HZNP) Tops Q2 Earnings and Revenue Estimates Zacks
07:45AM  Horizon Pharma: 2Q Earnings Snapshot Associated Press
07:00AM  Horizon Pharma plc Reports Record Quarterly Net Sales for Orphan and Rheumatology Segment; Increases Full-Year 2018 Adjusted EBITDA Guidance; Implements New Company Operating Structure to Enhance Focus on Rare Diseases Business Wire
Aug-06-18 11:21AM  Is a Beat in Store for Horizon Pharma (HZNP) in Q2 Earnings? Zacks
Jul-25-18 09:00AM  PEOPLE and Great Place to Work® Name Horizon Pharma plc to 2018 50 Companies That Care List Business Wire
Jul-23-18 03:05PM  7 Healthcare Stocks That Are Coming to Life InvestorPlace
Jul-19-18 07:50AM  Initiating Free Research Reports on Horizon Pharma and Three Other Healthcare Equities ACCESSWIRE
Jul-16-18 08:30AM  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering RAVICTI® (glycerol phenylbutyrate) Oral Liquid Business Wire
Jul-10-18 09:30AM  HZNP vs. LGND: Which Stock Is the Better Value Option? Zacks
Jul-09-18 08:30AM  Horizon Pharma plc to Release Second-Quarter 2018 Financial Results and Host Webcast on August 8, 2018 Business Wire
Jul-03-18 03:08PM  10 Underappreciated Biotech Stocks to Buy Kiplinger
Jun-18-18 07:05AM  Free Research Reports on Ironwood Pharma and Three More Generic Drugs Stocks ACCESSWIRE
Jun-15-18 07:00AM  Watertown biotech Selecta touts improved gout drug data in trial American City Business Journals
05:45AM  Horizon Pharma plc Presents Data at EULAR 2018 Advancing the Understanding and Management of Uncontrolled Gout GlobeNewswire
Jun-14-18 04:50AM  Epidemiologic Study Findings Show 27 Percent Increase in Emergency Department Visits for Gout in the United States Over the Past Decade GlobeNewswire
Jun-11-18 08:20AM  Today's Research Reports on Trending Tickers: Teva Pharmaceutical and Horizon Pharma ACCESSWIRE
Jun-08-18 10:13AM  Why Is Horizon Pharma (HZNP) Up 18.3% Since Its Last Earnings Report? Zacks +5.63%
Jun-07-18 07:40AM  Report: Exploring Fundamental Drivers Behind Horizon Pharma Public, Lululemon Athletica, Nordic American Tankers, UBS Group AG, 21Vianet Group, and Sandstorm Gold New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jun-06-18 10:02AM  What You Must Know About Horizon Pharma Public Limited Companys (NASDAQ:HZNP) Financial Strength Simply Wall St.
Jun-04-18 08:00AM  Horizon Pharma plc and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention GlobeNewswire
Jun-01-18 05:08PM  Kitov (KTOV) Gets Approval from FDA for Consensi, Shares Up Zacks
May-30-18 08:00AM  Horizon Pharma plc to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference GlobeNewswire
May-29-18 08:30AM  Today's Research Reports on Trending Tickers: Horizon Pharma and The Medicines Company ACCESSWIRE
May-22-18 06:13PM  Edited Transcript of HZNP earnings conference call or presentation 9-May-18 12:00pm GMT Thomson Reuters StreetEvents
10:15AM  Horizon Pharma plc Named One of the Best Small and Medium Workplaces in Chicago by FORTUNE GlobeNewswire
09:00AM  Horizon Pharma plc Launches GoutRevealed.com to Spotlight the Journey and Stories of People Living with Uncontrolled Gout GlobeNewswire
May-14-18 02:54PM  Phase two of clinical gout trial begins at UAB American City Business Journals +5.12%
May-11-18 07:00AM  Free Daily Technical Summary Reports on Horizon Pharma and Three More Generic Drugs Stocks ACCESSWIRE
May-10-18 10:33AM  Horizon Pharma (HZNP) Q1 Earnings & Sales Miss, Shares Fall Zacks
08:30AM  Today's Research Reports on Trending Tickers: Horizon Pharma and Ironwood Pharmaceuticals ACCESSWIRE
May-09-18 08:00AM  Horizon Pharma (HZNP) Q1 Loss Wider, Revenues Miss Zacks -5.60%
07:35AM  Horizon Pharma: 1Q Earnings Snapshot Associated Press
07:00AM  Horizon Pharma plc Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth; Increases Full-Year 2018 Guidance and Announces New Company Operating Structure to Enhance Focus on Rare Diseases GlobeNewswire
May-08-18 12:51PM  What Are Analysts Saying About Horizon Pharma Public Limited Companys (NASDAQ:HZNP) Earnings Trajectory? Simply Wall St.
08:00AM  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering RAVICTI® (glycerol phenylbutyrate) Oral Liquid GlobeNewswire
May-04-18 08:00AM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
May-03-18 08:39AM  Zacks.com highlights: Western Digital, Daqo New Energy, Horizon Pharma Public and American Axle & Manufacturing Holdings Zacks
08:00AM  Horizon Pharma plc Announces Sangita Iyer as a 2018 Healthcare Businesswomens Association Rising Star GlobeNewswire
May-02-18 08:16AM  4 Low P/CF Stocks Ready to Add Value to Your Investment Zacks
May-01-18 08:00AM  Horizon Pharma plc to Participate in the UBS Global Healthcare Conference GlobeNewswire +6.95%
Apr-20-18 08:39AM  Eleven Biotherapeutics (EBIO) in Focus: Stock Moves 8.7% Higher Zacks
Apr-18-18 06:33AM  Zacks.com highlights: Western Digital, ArcelorMittal, Arrow Electronics and Horizon Pharma Public Zacks
Apr-17-18 09:38AM  Pick These 4 Low P/CF Stocks & Sail Through a Volatile Market Zacks
Apr-12-18 04:30PM  Horizon Pharma plc Named No. 1 Biopharma Company to Work for by Great Place to Work® and FORTUNE GlobeNewswire
Apr-11-18 08:20AM  New Research: Key Drivers of Growth for Talend S.A, Chipmos Technologies, POSCO, Horizon Pharma Public, BioSpecifics Technologies, and Arbutus Biopharma Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-09-18 08:00AM  Horizon Pharma plc to Release First-Quarter 2018 Financial Results and Host Webcast on May 9, 2018 GlobeNewswire
Apr-06-18 09:27AM  4 Drug/Biotech Stocks to Buy Ahead of World Health Day Zacks
05:00AM  When These New Pharma Bros Show Up, Drug Prices Tend to Go Monumentally Higher Bloomberg
Apr-05-18 10:37AM  Conatus' Emricasan Fails in Phase II Study, Shares Sink Zacks
Apr-04-18 08:00AM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Apr-02-18 09:56AM  Amgen's Blincyto Gets FDA Nod for Minimum Residual Disease Zacks
05:56AM  Horizon Pharma (HZNP) Down 3.9% Since Earnings Report: Can It Rebound? Zacks
Mar-31-18 07:00AM  3 Top Value Stocks to Buy Right Now Motley Fool
Mar-29-18 05:31PM  Edited Transcript of HZNP earnings conference call or presentation 28-Feb-18 1:00pm GMT Thomson Reuters StreetEvents
07:45AM  Is a Recession in the Cards? 4 Safe Bets for Your Portfolio Zacks
Mar-27-18 10:08AM  Protagonist Therapeutics Stalls Ulcerative Colitis Study Zacks
Mar-26-18 10:20AM  Pfizer's Chantix Fails in Phase IV Study in Young Smokers Zacks
09:40AM  Clovis Gets Positive CHMP Opinion for Ovarian Cancer Drug Zacks
Mar-21-18 10:55AM  Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion Zacks
08:47AM  Ignore Trump's Pricing Rhetoric With These 5 Biotech Picks Zacks
Mar-20-18 11:49AM  Heron's Pain Candidate Meets Endpoint in Pivotal Studies Zacks
11:43AM  Arena's (ARNA) Etrasimod Meets Phase II Colitis Study Goal Zacks
Mar-19-18 10:18AM  Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up Zacks
Mar-15-18 10:00AM  Is Horizon Pharma Public (HZNP) a Great Stock for Value Investors Right Now? Zacks
08:09AM  Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo Forbes
Mar-13-18 04:32PM  Cantor Fitzgerald Names 8 Upcoming Biotech Catalysts Benzinga
Horizon Pharma Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally. The company's marketed medicine portfolio consists of RAVICTI for the treatment of urea cycle disorders; PROCYSBI to treat nephropathic cystinosis; ACTIMMUNE for the treatment of chronic granulomatous disease and malignant osteopetrosis; BUPHENYL to treat urea cycle disorders; and QUINSAIR for the treatment of chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients. Its products also include KRYSTEXXA to treat chronic refractory gout; RAYOS/LODOTRA for the treatment of rheumatoid arthritis, polymyalgia rheumatic, systemic lupus erythematosus, and various other indications; PENNSAID 2% to treat pain of osteoarthritis of the knees; DUEXIS for the treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis; VIMOVO to treat signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; and MIGERGOT for the treatment of vascular headache. The company has collaboration agreement with Fox Chase Cancer Center to evaluate ACTIMMUNE in combination with PD-1/PD-L1 inhibitors in various forms of cancer; Alliance for Lupus Research to evaluate RAYOS/LODOTRA on the fatigue experienced by systemic lupus erythematosus patients; and Syneos Health, Inc. in connection with its Phase III confirmatory trial to evaluate teprotumumab for the treatment of thyroid eye disease. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CURTIS GEOFFREY M.EVP, Corporate Affairs, CCOAug 16Sale20.639,904204,36128,767Aug 20 04:29 PM
Beeler Brian KEVP, General CounselJun 08Sale17.5815,433271,24979,530Jun 12 05:00 PM
Walbert Timothy PChairman, President and CEOJun 01Option Exercise10.4383,353869,372629,423Jun 05 04:13 PM
Walbert Timothy PChairman, President and CEOJun 01Sale16.1783,3531,348,218546,070Jun 05 04:13 PM
Beeler Brian KEVP, General CounselMay 25Option Exercise2.4048,000115,200110,524May 30 04:49 PM
Beeler Brian KEVP, General CounselMay 25Sale16.1117,931288,86892,593May 30 04:49 PM
Walbert Timothy PChairman, President and CEOJan 02Option Exercise0.0049,5000497,701Jan 03 06:25 PM
open in yahoo | open in reuters | open in google